NeuroSense Therapeutics Ltd.
NRSN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3,378 | $2,640 | $3,543 | $11,063 |
| Short-Term Investments | $0 | $0 | $3,547 | $0 |
| Receivables | $164 | $166 | $131 | $178 |
| Inventory | $0 | $0 | -$3,678 | -$178 |
| Other Curr. Assets | $860 | $110 | $3,838 | $349 |
| Total Curr. Assets | $4,402 | $2,916 | $7,381 | $11,412 |
| Property Plant & Equip (Net) | $150 | $238 | $306 | $19 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $23 | $22 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $9 | $23 | $0 |
| Total NC Assets | $173 | $269 | $329 | $19 |
| Other Assets | $0 | -$9 | $0 | $0 |
| Total Assets | $4,575 | $3,176 | $7,710 | $11,431 |
| Liabilities | – | – | – | – |
| Payables | $1,160 | $1,459 | $498 | $39 |
| Short-Term Debt | $146 | $138 | $128 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $686 | $1,862 | $1,100 | $558 |
| Total Curr. Liab. | $1,992 | $3,459 | $1,726 | $597 |
| LT Debt | $0 | $73 | $147 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $1,412 | $218 | $1,828 |
| Total NC Liab. | $0 | $1,591 | $365 | $1,828 |
| Other Liabilities | $0 | -$106 | $0 | $0 |
| Cap. Leases | $73 | $142 | $211 | $0 |
| Total Liabilities | $1,992 | $4,944 | $2,091 | $2,425 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$36,660 | -$26,121 | -$20,786 | -$8,446 |
| AOCI | $0 | $24,362 | $26,405 | $0 |
| Other Equity | $39,243 | $24,247 | $21,858 | $17,452 |
| Total Equity | $2,583 | -$1,874 | $5,619 | $9,006 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $4,575 | $3,176 | $7,710 | $11,431 |
| Net Debt | -$3,232 | -$2,429 | -$3,268 | -$11,063 |